Adequacy of peritoneal dialysis after the ADEMEX study. Back to the basics

International Journal of Artificial Organs

Volumn 25, Issue 9, 2002, Pages 827-831

  Tzamaloukas, Antonios H ^a,b   Murata, G H ^a,b  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERITONEAL DIALYSIS;

CREATININE; GLUCOSE; UREA;

ANEMIA; BIOCOMPATIBILITY; CLINICAL TRIAL; CREATININE CLEARANCE; DIALYSATE; EDITORIAL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KINETICS; MALNUTRITION; MEDICAL RESEARCH; METABOLIC DISORDER; MORTALITY; OBESITY; PERITONEAL DIALYSIS; PREDICTION; RESIDUAL URINE; SURVIVAL; ULTRAFILTRATION; UREMIA; URINE VOLUME;

EID: 0036770599     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202500903     Document Type: Editorial

References (30)

1. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effects of hemodialysis prescription on patient morbidility: Report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305: 1176-81.
2. Gotch FD, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-34.
3. Held PJ, Port FK, Wolf RA, Stannard DC, Carroll CE, Daugirdas JT, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50: 550-6.
4. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999; 55: 1560-7.
5. Kopple JD, Zhu X, Lew DL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56: 1135-48.
6. Lowie EG, Chertow GM, Lew NL, Lazarus JM, Owen WF. The urea product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 1999; 56: 729-37.
7. Port FK, Ashby VB, Dhingra RK, Roys EL, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-6.
8. Teehan BP, Schleifer CR,, Sigler MH, Gilgore GS. A quantitative approach to the CAPD prescription. Perit Dial Bull 1985; 5: 152-6.
9. Keshaviah PR, Nolph KD, Van Stone JC. The peak concentration hypothesis: A urea kinetic approach to comparing the adequency of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Perit Dial Int 1989; 9: 267-60.
10. Churchill DN, Taylor DW, Keshaviah PR, Thorpe KE, Beecroft ML. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198-207.
11. Bargman JM, Thorpe KF, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158-62.
12. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Zhu X, Lazarus JM. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 1999; 3: 523-34.
13. Bhaskaran S, Schaubel DE, Jassal SV, et al. The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int 2000; 20: 181-7.
14. Aslam N, Bernardini J, Fried L, Piraino B. Peritoneal dialysis clearance can replace residual renal function. Perit Dial Int 2001; 21: 263-8.
15. Szeto CC, Wong TYH, Chow KM, Leung CB, Law MC, Wang AYM, et al. Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001; 12: 355-60.
16. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearance on mortality rates in peritoneal dialysis: ADEMEX, a prospective randomized controlled trial. J Am Soc Nephrol 2002; 13: 1307-20.
17. Chatoth DK, Golper TA, Gokal R. Morbidity and mortality in redefining adequacy of peritonel dialysis: A step beyond the National Kidney Foundation Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1999; 33: 617-32.
18. Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis 2000; 35: 69-79.
19. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JGP, Stevens P, et al. Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney Int 1999; 55: 1476-85.
20. Scribner BH, Buri R, Caner JEJ, Hegstrom R, Burnell JM. The treatment of chronic uremia by means of intermittent hemodialysis: A preliminary report. ASAIO Trans 1960; 6: 114-22.
21. Tzamaloukas AH, Saddler MC, Murata GH, Malhotra D, Sena P, Simon D, et al. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995; 6: 198-206
22. Cocchi R, Esposti ED, Fabbri A, Lucatello A, Sturani A, Quarello F, et al. Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14: 1536-40.
23. Lang SM, Wolfram G, Gerger R, Schiffl H. Characterization of subtypes of hypertension in CAPD patients by cyclic guanosine monophosphate. Perit Dial Int 1999; 19: 143-7.
24. Takeda K, Nakamoto M, Baba M, Tanaka T, Yasunaga C, Mishikava G, et al. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients. Clin Nephrol 1998; 49: 308-12.
25. Buoncristiani U, Ceravolo G, Bova C. Reversal of left-ventricular hypertrophy in uremic patients by treatment with dialy hemodialysis (DHD). Contrib Nephrol 1996; 119: 152-6.
26. 2001 Annual Report: ESRD Clinical Performance Measures Project. Am J Kidney Dis 2002; 39 (suppl 2): S4-98.
27. Goodman WG, Goldin J, Kuison BD, Yoon C, Cales B, Sider D, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing hemodialysis. N Engl J Med 2000; 342: 1478-83.
28. Chertwo GM, Burke SK, Raggi P, for the Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-52.
29. Tzamaloukas AH. Peritoneal toxicities of hypertonic dextrose dialysate. Adv Perit Dial 1999; 15: 217-21.
30. Tzamaloukas AH. Avoiding the use of hypertonic dextrose dialysate. Semin Dial 1999; 13: 156-9.